Sökresultat - Colin D. Mansfield

  • Visas 1 - 12 av 12 resultat
Förfina resultatet
  1. 1
    ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?

    ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? av D. S. Petrov, Colin D. Mansfield, Alain Moussy, Olivier Hermine

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  2. 2
    Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model

    Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model av Martine Humbert, Nathalie Castéran, Sébastien Létard, Katia Hanssens, Juan Iovanna, Pascal Finetti, François Bertucci, Thomas Bader, Colin D. Mansfield, Alain Moussy, Olivier Hermine, Patrice Dubreuil

    Publicerad 2010
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

    Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial av Bruno Dubois, Jesús López‐Arrieta, Stanley Lipschitz, Triantafyllos Doskas, Luiza Spiru, Svitlana Moroz, Olena Venger, Patrick Vermersch, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Magda Tsolaki

    Publicerad 2023
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    Long-term survival analysis of masitinib in amyotrophic lateral sclerosis

    Long-term survival analysis of masitinib in amyotrophic lateral sclerosis av Jesús S. Mora, Walter G. Bradley, Delia Chaverri, María Hernández-Barral, Javier Mascías, Josep Gámez, Gisella Gargiulo‐Monachelli, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Albert C. Ludolph

    Publicerad 2021
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

    Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study av Jacques Tébib, Xavier Mariette, Pierre Bourgeois, René‐Marc Flipo, Philippe Gaudin, Xavier Le Loët, Paul Gineste, Laurent Guy, Colin D. Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine, Jean Sibilia

    Publicerad 2009
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study

    Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study av C. Paul, B. Sans, Felipe Suárez, Philippe Casassus, Stéphane Barète, Fanny Lanternier, Catherine Grandpeix‐Guyodo, Patrice Dubreuil, Fabienne Palmérini, Colin D. Mansfield, Paul Gineste, Alain Moussy, Olivier Hermine, Olivier Lortholary

    Publicerad 2010
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer

    A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer av G. Deplanque, Martin Demarchi, Mohamed Hebbar, Patrick J. Flynn, Bohuslav Melichar, J. Atkins, Elżbieta Nowara, Lem Moyé, David Piquemal, D. Ritter, Patrice Dubreuil, Colin D. Mansfield, Y. Acin, Alain Moussy, Olivier Hermine, Pascal Hammel

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT

    Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT av Patrice Dubreuil, Sébastien Létard, Marco A. Ciufolini, Laurent Gros, Martine Humbert, Nathalie Castéran, Laurence Borge, Bérengère Hajem, Anne Lermet, Wolfgang Sippl, Edwige Voisset, Michel Arock, Christian Auclair, Phillip S. Leventhal, Colin D. Mansfield, Alain Moussy, Olivier Hermine

    Publicerad 2009
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

    Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial av Antoine Adenis, Jean‐Yves Blay, B. Bui-Nguyen, Olivier Bouché, François Bertucci, Nicolás Isambert, Emmanuelle Bompas, L. Chaigneau, Julien Dômont, Isabelle Ray‐Coquard, Aurore Blesius, Brian A. Van Tine, V.R. Bulusu, Patrice Dubreuil, Colin D. Mansfield, Y. Acin, Alain Moussy, Olivier Hermine, Axel Le Cesne

    Publicerad 2014
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

    Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial av Jesús S. Mora, Angela Genge, Adriano Chió, Conrado J. Estol, Delia Chaverri, Mariluz Hernández, Saúl Marín, Javier Mascías, Gabriel Rodríguez, Mònica Povedano, Andrés Paipa, Raúl Domínguez, Josep Gámez, María Salvadó, Christian Lunetta, Carlos Ballario, Nilo Riva, Jessica Mandrioli, Alain Moussy, Jean‐Pierre Kinet, Christian Auclair, Patrice Dubreuil, Vincent Arnold, Colin D. Mansfield, Olivier Hermine

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

    Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study av Olivier Lortholary, Marie‐Olivia Chandesris, C. Bulaï Livideanu, C. Paul, G. Guillet, Ewa Jassem, Marek Niedoszytko, Stéphane Barète, Srđan Verstovšek, Clive Grattan, Gandhi Damaj, Danielle Canioni, Sylvie Fraïtag, Ludovic Lhermitte, S. Georgin Lavialle, Laurent Frenzel, Lawrence B. Afrin, Katia Hanssens, Julie Agopian, Raphaël Gaillard, Jean-Pierre Kinet, Christian Auclair, Colin D. Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine

    Publicerad 2017
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis

    Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis av Patrick Vermersch, Luís Brieva, Robert J. Fox, Friedemann Paul, Lluís Ramió‐Torrentà, Matthias Schwab, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Maciej Maciejowski, Nassima Hecham, Norma Deri, Jasminka Djelilović-Vranić, Ivan Milanov, Penko Shotekov, Gregg Blevins, J Girard, Yves Lapierre, William Camu, Giovanni Castelnovo, Pierre Clavelou, Patrick Hautecœur, Martin Marziniak, Christoph Mayer, Patrick Oschmann, Gerd Reifschneider, I. Schoell, Björn Tackenberg, Florian Then Bergh, Ν. Fakas, Nikolaos Grigoriadis, D. Kalochristianakis, Dimos D. Mitsikostas, Anastasios Orologas, Antonios Tavernarakis, Thomas Thomaidis, Krisztina Kovács, K Mátyás, Pálma Piros, Mária Sátori, K.J.S. Anand, Alexander L. Shifrin, Krzysztof Banaszkiewicz, Robert Bonek, M. Chahwan, M. Czernichowska - Kotiuszko, Lidia Darda-Ledzion, J. D. Wojcik, M Dziki, Ewa Krzystanek, Marianna Kulka, Paweł Lisewski, Marcin Ratajczak, Andrzej Szczudlik, Jarosław Szczygieł, Małgorzata Pańczyk-Tomaszewska, Jacek Wójcik, Daniel Zielonka, M. Chiru, Swaroopa Deme, S Mănescu, S.A. Nica, Christian Popescu, Szabolcs Szatmári, A. L. Fedyanin, N A Malkova, D.V. Popov, Л. И. Волкова, Vorob'eva Ov, M Brozman, Andrea Cimprichová, P. Cuchran, Ladislav Gurcik, Georgi Krastev, I. Lisá, M. Nyeky, J. Poljaková, Peter Turčáni, Adaani Frost, Josef G. Heckmann, Eduardo Agüera, Francisco Coret, Antonio Escartín, Victoria Fernández, JR. Ara Callizo, Greg S. Martin, José Rodríguez, M. Martinez Gines, Daniel Muñoz, Javier Olascoaga, José M. Prieto, Cristina Ramo‐Tello, Samir Belal, S. Ben Ammou, Mahbouba Frih-Ayed, Riadh Gouider, Chokri Mhiri, Ridha Mrissa, Alla Cherkez, H. Chmyr

    Publicerad 2022
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: